Myanmar vs Turkmenistan: Prevalence rate of hypertension in women aged 30-79
Myanmar
40
in 2019
Turkmenistan
40.2
in 2019
Myanmar rank
80th
Turkmenistan rank
78th
Prevalence rate of hypertension in women aged 30-79 over time
- Myanmar
- Turkmenistan
How they compare
Turkmenistan currently reports 40.2 against 40 in Myanmar, a difference of 0.2.
Across all 30 years both countries report, Turkmenistan has been ahead every year.
Myanmar ranks 80th and Turkmenistan ranks 78th of 195 countries.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 31.72 | 38.44 | 6.72 | Turkmenistan |
| 2000s | 34.79 | 39.65 | 4.86 | Turkmenistan |
| 2010s | 38.55 | 40.46 | 1.91 | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Myanmar or Turkmenistan?
- Turkmenistan, at 40.2 against 40 in Myanmar as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Myanmar and Turkmenistan?
- 0.2, with Turkmenistan ahead.
- How many years of comparable data are there for Myanmar and Turkmenistan?
- 30 years are reported by both, from 1990 to 2019.
- How do Myanmar and Turkmenistan rank globally for prevalence rate of hypertension in women aged 30-79?
- Myanmar ranks 80th and Turkmenistan ranks 78th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.